MedTrace Logo

Omegia Softgel Clinical Research Program

NCT05872178 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-05-24

No results posted yet for this study

Summary

Evaluate the improvement of regulation of skin and blood index composition after consumption of Omegia® Softgel

Conditions

  • Skin Manifestations
  • Antioxidative Stress
  • Eye Strain
  • Vaginal Disease

Interventions

DIETARY_SUPPLEMENT

Omegia® Softgel -B

How to use: Take once a day for 12 weeks Subject precautions: If the health products and cosmetic care products used contain sea buckthorn ingredients, stop using them.

DIETARY_SUPPLEMENT

Omegia® Softgel -A

How to use: Take once a day for 12 weeks Subject precautions: If the health products and cosmetic care products used contain sea buckthorn ingredients, stop using them.

Sponsors & Collaborators

  • Chia Nan University of Pharmacy ＆ Science

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05872178 on ClinicalTrials.gov